Stockreport

Epizyme As A Strategic Acquisition For Epigenetic Therapies [Seeking Alpha]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF Epizyme As A Strategic Acquisition For Epigenetic Therapies Summary Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovere [Read more]